Covid-19 vaccine: US approves restart of Johnson & Johnson jabs
Johnson & Johnson’s COVID-19 vaccinations can restart, United States (US) health regulators said on April 23, after the shots’ rollout was paused due to worries over blood clotting.
Health authorities in the US April 14 proposed a halt on the vaccine following instances of severe blood clots among a handful of the millions of Americans who received the vaccine.
The news came shortly after an expert panel recommended lifting the pause because the shots benefits exceeded possible dangers.
“We have concluded that the known and potential benefits of the Janssen COVID-19 vaccine outweigh its known and potential risks in individuals 18 years of age and older,” said Janet Woodcock, head of Food and Drug Administration (FDA) in a joint statement with the Centers for Disease Control and Prevention (CDC).